Receptor-interacting protein kinase 3-mediated programmed cell necrosis in rats subjected to focal cerebral

Yanru Dong1, Cuifen Bao2, Jingwei Yu1

  • 1Department of Histology and Embryology, Liaoning Medical University, Jinzhou, Liaoning 121001, P.R. China.

Insights

Caspase blockade enhances receptor-interacting protein kinase 3 (RIP3)-mediated cell necrosis following cerebral ischemia-reperfusion injury (CIRI). This effect is independent of tumor necrosis factor-α receptor 1 (TNFR1) signaling.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Cerebral ischemia-reperfusion injury (CIRI) is a critical condition leading to neuronal damage.
  • Tumor necrosis factor-α receptor 1 (TNFR1) and receptor-interacting protein kinase 3 (RIP3) are implicated in cell death pathways.
  • Understanding the roles of TNFR1 and RIP3 in CIRI is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the activation of TNFR1 and RIP3 in a rat model of CIRI.
  • To determine the effect of caspase blockade using Z-VAD-FMK (zVAD) on RIP3 and TNFR1 expression and neuronal necrosis.
  • To elucidate the relationship between zVAD, RIP3, TNFR1, and cell death in CIRI.

Main Methods:

  • A rat model of CIRI was established using middle cerebral artery embolization.
  • Neurological scores, TTC staining, and brain water content were used to confirm the CIRI model.
  • Immunohistochemistry and Western blotting were employed to assess TNFR1 and RIP3 expression.

Main Results:

  • Neuronal necrosis was observed starting at 6 hours post-CIRI and increased with duration.
  • Both TNFR1 and RIP3 expression were upregulated following CIRI, with levels increasing over time.
  • zVAD treatment increased RIP3 protein levels and reduced necrosis but did not affect TNFR1 levels.

Conclusions:

  • RIP3-mediated cell necrosis is enhanced by caspase blockade with zVAD following CIRI.
  • The protective function of zVAD in this context is independent of TNFR1 signaling.
  • These findings highlight RIP3's role in CIRI-induced necrosis and suggest potential therapeutic targets.